You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-Cov2

Showing 26 - 50 of 5,886
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

Recruiting
  • COVID-19
  • SARS-CoV-2 DNA Vaccine (ICCOV)
  • Wong Chuk Hang, Hong Kong
    Gleneagles Hospital Hong Kong
Jun 16, 2023

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

Active, not recruiting
  • SARS-CoV-2 RNA Vaccines
  • HIV Infection
  • SARS-CoV-2 Vaccine
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Dec 1, 2022

SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 variant mRNA vaccine low dose
  • SARS-CoV-2 variant mRNA vaccine high dose
  • (no location specified)
Oct 30, 2022

Sars-Covid-19 Vaccines in Haematological Patients: Prospective

Completed
  • Hematologic Diseases
  • IgG antibodies to Sars-Cov-2
  • QuantiFERON SARS-CoV-2 test
  • Monza, Lombardia, Italy
    San Gerardo Hospital
Jan 23, 2023

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

SARS-CoV-2 Infection Trial in Beijing (HH-120 nasal spray 1, HH-120 nasal spray 2, Placebo Comparator 1)

Completed
  • SARS-CoV-2 Infection
  • HH-120 nasal spray 1
  • +3 more
  • Beijing, Beijing, China
    Beijing Ditan Hospital,Capital Medical University
Mar 1, 2023

End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications Trial (Offering SARS-CoV-2 test)

Not yet recruiting
  • End-stage Renal Disease
  • +2 more
  • Offering SARS-CoV-2 test
  • (no location specified)
Dec 12, 2022

SARS-CoV-2 Trial (SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine high

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine low dose
  • +2 more
  • (no location specified)
Dec 1, 2022

Covid19 Trial in Cypress (VXA-CoV2-1)

Completed
  • Covid19
  • VXA-CoV2-1
  • Cypress, California
    WCCT
Jan 17, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose, SARS-CoV-2 Variant (Omicron BA.5) mRNA

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine Low dose
  • +2 more
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Jan 3, 2023

COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of

Enrolling by invitation
  • COVID-19
  • +2 more
  • Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
  • Kunming, Yunnan, China
    Sheng'Ai Traditional Medicine Hospital
Sep 22, 2023

Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)

Completed
  • Sars-CoV-2 Infection
  • COVID-19
  • Rapid SARS-CoV-2 Antigen Test
  • Knoxville, Tennessee
    EDP Biotech Corporation
Oct 14, 2022

SARS-CoV-2 Infection Trial in Shinagawa-ku (S-217622, Placebo)

Recruiting
  • SARS-CoV-2 Infection
  • Shinagawa-ku, Higashioi, Japan
    Tokyo Shinagawa Hospital Social Medical Corporation Association
Jun 13, 2023

SARS-CoV-2 IgG and IgM Serologic Assays

Active, not recruiting
  • Covid19
  • Serologic assays for antibodies to SARS-CoV-2
  • Detroit, Michigan
    Henry Ford Health System
Dec 13, 2022

SARS-CoV-2 Infection in Hematologic Tumors

Active, not recruiting
  • SARS-CoV-2 Infection
  • Hematologic Malignancy
  • None intervention
  • Beijing, Beijing, China
    Peking University First Hospital
Jan 13, 2023

COVID-19, SARS-CoV-2 Trial in Seoul (QTP104 1ug, QTP104 5ug, QTP104 25ug)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • QTP104 1ug
  • +2 more
  • Seoul, Korea, Republic of
  • +1 more
May 24, 2023

Vitamin D and Vitamin D Binding Protein With Disease Severity in

Active, not recruiting
  • SARS CoV-2 Infection
  • Vitamin D Binding protein
  • Istanbul, Turkey
    Haseki Training and Research Hospital
Nov 1, 2022

EuGeni Rapid Antigen Test for Qualitative Detection of Severe

Terminated
  • SARS-CoV-2 Infection
  • EuGeni SARS-CoV-2 Antigen Rapid Diagnostic Test
  • Split, Croatia
  • +4 more
Jan 3, 2023

Viral Dynamics of Omicron in Children

Completed
  • SARS-CoV2 Infection, COVID-19
  • Daily SARS-CoV-2 PCR Testing for 10 days
  • Toronto, Ontario, Canada
    The Hospital for Sick Children
Nov 25, 2022

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

Completed
  • COVID-19
  • SARS-CoV-2 Infection
  • Quantitative analysis of SARS-CoV-2 antibodies
  • Cellular immunity
  • Prague, Czechia
    Institute of Health Information and Statistics of the Czech Repu
Nov 25, 2022

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.

Not yet recruiting
  • SARS-CoV-2 Infection
  • Biological assays
  • Vandoeuvre Les Nancy, France
    Schvoerer
Oct 1, 2022

Vitamin A and E Deficiency With Severity of SARS-COV-2 Disease:

Completed
  • COVID-19
    • Cairo, None Selected, Egypt
      balsam Sherif Fahmy
    Jul 12, 2023

    SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)

    Not yet recruiting
    • SARS CoV-2 Post-Acute Sequelae
    • DPA-714 PET/MRI
    • Birmingham, Alabama
      UAB
    Dec 16, 2022

    SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

    Recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
    • Saline solution
    • Bengbu, Anhui, China
      First Affiliated Hospital Bengbu Medical College
    Feb 26, 2023

    CORONABED.BOT -COVID-19:Automation Project Using Artificial

    Recruiting
    • SARS-CoV-1 Infection
    • Artificial Intelligence methods
    • Rome, Italy
      Fondazione Policlinico Gemelli
    Mar 28, 2023